advertisement
Journal of Ocular Pharmacology and Therapeutics 20
Showing records 1 to 20 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics108471 Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase
Wiggins SV
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 317-323
108022 Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders
Wilson SE
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 191-206
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Sturdivant J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
108310 Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review
Daull P
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 240-251
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Wu P; Wang Z
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108310 Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review
Garrigue JS
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 240-251
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Williams SS
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
108471 Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase
Schreiner R; Ferreira J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 317-323
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Liang L
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Ina M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
108310 Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review
Liang H
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 240-251
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Weksler M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
108471 Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase
Marmorstein AD
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 317-323
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Chen B
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
108310 Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review
Baudouin C
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 240-251
108471 Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase
Levin LR
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 317-323
107637 Characteristics of Mitomycin C-Loaded Peptide Hydrogel and Antiscarring Effects in Rat Ocular Injury Model
Xu N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 139-147
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
McDougal A; Clancy D
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
108471 Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase
Buck J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 317-323
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
deLong MA; Girouard N; Zaretskaia M; Brennan K; Glendenning A; Foley B; Lin CW; White JC; Kopczynski C; Kelly CR
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127